The alterations mediated by promoter hyper-methylation and epigenetic inactivation of CDH1 has been found most commonly in DGC, playing a vital role as a second-hit mechanism in deregulation of the wild-type of CDH1 in HDGC patients [34,67]. The gene discussed is CDH1; the disease is Familial gastric cancer.